Kara Gooding, PA-C: Decoding Benign Versus Malignant Pink Lesions

Kara Gooding, PA-C, shares valuable insights on decoding benign versus malignant pink bumps based on a presentation at DEF Essential Resource Meeting 2026 (DERM2026) NP/PA CME Conference. Drawing from her clinical practice, she explains that evaluating a lesion’s history, location, and symptoms like bleeding or pain is critical because dermoscopy is less effective for nonpigmented bumps. She highlights the danger of Merkel cell carcinoma, a highly metastatic tumor linked to UV radiation and the Merkel cell polyoma virus that can easily go undetected on standard CT scans. Ultimately, she utilizes real case studies from her own career to demonstrate how lethal cancers and amelanotic melanomas can masquerade as common warts, nevi, or dermatofibromas, reminding clinicians to critically evaluate every innocent-looking bump.

MORE DEF 2026 CONFERENCE COVERAGE:

Alexa Hetzel, PA-C: Tips for Publishing a Case Report
Alexa Hetzel, PA-C, outlines the journey of getting a case study published. The process begins with picking an interesting patient case, thoroughly documenting the treatment
David Cotter, MD, PhD: Emerging Technologies for Moles and Melanoma

Dr. Cotter explores emerging technologies that may enhance the evaluation, risk stratification, and monitoring of melanoma and atypical melanocytic lesions. He reviews tools ranging from

Andrea Nguyen, PA-C, MS: Poster Session Highlights
Andrea Nguyen, PA-C, MS, summarized several key poster presentations based on a presentation at DEF Essential Resource Meeting 2026 (DERM2026) NP/PA CME Conference. The first
Suneel Chilukuri, MD: Regenerative Medicine and the Future of Scar Treatment
Dr. Chilukuri highlighted the evolving field of regenerative medicine and its crossover with other anti-inflammatory disciplines based on a presentation at DEF Essential Resource Meeting
Andrew Mastro, MS, PA-C: Case Pearls and Clinical Dilemmas in Dermatology
Andrew Mastro, MS, PA-C, recounted his experience on a panel called "What's Behind the Curtain?" where experts answered top audience questions using case-based pearls based
David Cotter, MD, PhD: Empowering Clinical Decision-Making with Upadacitinib Data

Dr. Cotter explains how utilizing clinical trial data can help clinicians overcome therapeutic inertia regarding the use of JAK inhibitors for patients with atopic dermatitis

Andrew Blauvelt, MD, MBA: The Importance of 100% Skin Clearance in Psoriasis Management

Dr. Blauvelt highlights the clinical significance of aiming for 100% skin clearance in patients with psoriasis based on a presentation at DEF Essential Resource Meeting

Andrea Nguyen, PA-C, MS: Advancing Hidradenitis Suppurativa Care
Andrea Nguyen, PA-C, MS, provides a detailed recap of her presentation on HS, which addressed the critical need for a multifactorial management approach, highlighting the
Kara Gooding, PA-C: Advancing Your Career Through Negotiation, Advocacy, and Risk-Taking

Kara Gooding, PA-C, shares valuable insights on how speaking up, negotiating, and taking strategic risks can shape a successful medical career based on a presentation